83 related articles for article (PubMed ID: 7738664)
1. Assessing intratumor distribution and uptake with MBBG versus MIBG imaging and targeting xenografted PC12-pheochromocytoma cell line.
Clerc J; Mardon K; Galons H; Loc'h C; Lumbroso J; Merlet P; Zhu J; Jeusset J; Syrota A; Fragu P
J Nucl Med; 1995 May; 36(5):859-66. PubMed ID: 7738664
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of norepinephrine transporter-expressing tumors using 76Br-meta-bromobenzylguanidine.
Watanabe S; Hanaoka H; Liang JX; Iida Y; Endo K; Ishioka NS
J Nucl Med; 2010 Sep; 51(9):1472-9. PubMed ID: 20720048
[TBL] [Abstract][Full Text] [Related]
3. Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart.
Valette H; Loc'h C; Mardon K; Bendriem B; Merlet P; Fuseau C; Sabry S; Raffel D; Mazière B; Syrota A
J Nucl Med; 1993 Oct; 34(10):1739-44. PubMed ID: 8410291
[TBL] [Abstract][Full Text] [Related]
4. Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG).
Loc'h C; Mardon K; Valette H; Brutesco C; Merlet P; Syrota A; Maziere B
Nucl Med Biol; 1994 Jan; 21(1):49-55. PubMed ID: 9234263
[TBL] [Abstract][Full Text] [Related]
5. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
7. Kinetics of the norepinephrine analog [76Br]-meta-bromobenzylguanidine in isolated working rat heart.
Raffel D; Loc'h C; Mardon K; Mazière B; Syrota A
Nucl Med Biol; 1998 Jan; 25(1):1-16. PubMed ID: 9466356
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma.
Mozley PD; Kim CK; Mohsin J; Jatlow A; Gosfield E; Alavi A
J Nucl Med; 1994 Jul; 35(7):1138-44. PubMed ID: 8014671
[TBL] [Abstract][Full Text] [Related]
9. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
10. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
13. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
Shulkin BL; Shen SW; Sisson JC; Shapiro B
J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
[TBL] [Abstract][Full Text] [Related]
14. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison.
Bomanji J; Levison DA; Flatman WD; Horne T; Bouloux PM; Ross G; Britton KE; Besser GM
J Nucl Med; 1987 Jun; 28(6):973-8. PubMed ID: 3585505
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model.
Gaertner FC; Wiedemann T; Yousefi BH; Lee M; Repokis I; Higuchi T; Nekolla SG; Yu M; Robinson S; Schwaiger M; Pellegata NS
J Nucl Med; 2013 Dec; 54(12):2111-7. PubMed ID: 24136933
[TBL] [Abstract][Full Text] [Related]
16. Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.
Shulkin BL; Shapiro B; Tobes MC; Shen SW; Wieland DM; Meyers LJ; Lee HT; Petry NA; Sisson JC; Beierwaltes WH
J Nucl Med; 1986 Jul; 27(7):1138-42. PubMed ID: 3723189
[TBL] [Abstract][Full Text] [Related]
17. Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function.
Tobes MC; Fig LM; Carey J; Geatti O; Sisson JC; Shapiro B
J Nucl Med; 1989 Sep; 30(9):1476-82. PubMed ID: 2769403
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative radionuclear 125I-labeled metaiodobenzylguanidine scanning of pheochromocytomas and metastases.
Proye CA; Carnaille BM; Flament JB; Hossein-Foucher CA; Lecouffe PP; Marchandise XM; Lennquist S
Surgery; 1992 Jun; 111(6):634-9. PubMed ID: 1595059
[TBL] [Abstract][Full Text] [Related]
19. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
[TBL] [Abstract][Full Text] [Related]
20. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
